Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > They could be the ones shorting the stock...
View:
Post by donkeyfeathers on Nov 27, 2020 2:34pm

They could be the ones shorting the stock...

Add Johnson & Johnson to that list.  Once there was a serious researcher (Witkowski) put in charge, the real threat materialized.  Turf protection became more important than c-peptide protection.  As for Medtronic, they must wonder how they can monetize the platform across indications other than as an artificial pancreas.  Owning a F350 Lariet is great for utility, but is kind of out of place in an F1 competition.  Different specificities may not be what a Medtronic is after.  But all the large pharmaceuticals know that if islets survive without immunosuppressant, the game changes forever.  Now, can Frank and Phillip monetize THAT.
Comment by palladium17 on Nov 27, 2020 2:44pm
Thanks Donkey, finally some positive post.
Comment by woundedknee on Nov 27, 2020 2:51pm
Positive posts don't cut it. I'm starting to believe Biotech is making sense.
Comment by Redbaron2211 on Nov 27, 2020 3:40pm
Woundedknee Bio claims to own alot of shares he's just twisted. One day if he stops posting and moves on then it's a sign he truly doesn't see potential here. Until then he's more bullish then ever and his posts are satirical in nature and his purpose is to shame individuals/corporations into improvement. Seems to be a common methodology on this BB.
Comment by woundedknee on Nov 27, 2020 3:46pm
Yep..I hear ya. Have a good weekend.
Comment by BioTeck on Nov 27, 2020 4:13pm
Why do you guys have a problem with me venting on a public forum designed for this very purpose when I'm not impressed with what is happening with management of a company that I'm invested in? Are these boards only to spread good vibes and positivity? Why is it so difficult to understand that I'm here voicing my concerns with fellow shareholders and talking about the potential ...more  
Comment by elgin1 on Nov 27, 2020 5:27pm
Donkeyfeathers .... I agree having Witoski is probably the best thing Sva has going for it. He is highly credible and reputable. The study is air tight so the results will be in no question .   The only cards Sernova holds are the clinical results from the pouch trial. Sernova has no control over how to encourage a pharma into a collaboration. The clinical results when fully released will ...more  
Comment by Redbaron2211 on Nov 27, 2020 7:34pm
Bio not sure what your going on about with Cpetide any levels of Cpetide in a patient that has no ability to produce their own is significant.  In the past when I spoke to Philip about other hormones like glucagon he said they don't measure for it because it's unstable, not reliable and can be inferred from cpeptide.  The bottom line is we have 5 patients that have vascularized ...more  
Comment by Redbaron2211 on Nov 27, 2020 7:51pm
You have been "just venting" from day 1 I can't imagine having that much pressure to release. Anyways good points from everyone lots to think about waiting for hopefully a major catalyst.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse